dapsone has been researched along with Erythema in 61 studies
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A Burmese boy being treated with dapsone (diaminodiphenylsulfone [DDS]), 100 mg daily, for lepromatous leprosy had a fatal reaction to the drug 3 weeks after therapy was started." | 7.66 | Fatal reaction to dapsone during treatment of leprosy. ( Borkowsky, W; Bullock, WE; Frey, HM; Gershon, AA, 1981) |
| "A patient with a 20-year history is presented as a classic example of erythema elevatum diutinum, with a dramatic response to dapsone therapy, and with interesting features of improvement during pregnancies and occurrence of giant cell tumors of soft tissue, neither of these latter features having been previously reported." | 7.65 | Erythema elevatum diutinum. Response to dapsone. ( Fort, SL; Rodman, OG, 1977) |
| " Safety profile assessments included adverse events (AEs), physical examinations, laboratory tests, and local tolerability assessments." | 6.82 | Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. ( Berk, DR; Chang-Lin, JE; Jarratt, MT; Jones, TM; Kaoukhov, A; Lin, V; Tong, W, 2016) |
| "A 19-year-old Japanese man had been treated for ulcerative colitis for 2 years." | 5.37 | A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory ( Danno, K; Fujimoto, N; Tanaka, T; Uenishi, T; Wakabayashi, M, 2011) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 5.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| " Histological analysis of one of these nodules resulted in diagnosis of chronic erythema elevatum diutinum and treatment with dapsone was initiated." | 3.76 | [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. ( Andre, C; Bagot, M; Duriez, P; Lascaux-Cametz, AS; Maksimovic, L; Ortonne, N; Revuz, J, 2010) |
| "A 70-year-old man with erythema elevatum diutinum developed new lesions on his right hand 4 years after initiation of treatment with dapsone." | 3.67 | Unique aspects of a lesion of erythema elevatum diutinum. ( Alessi, E; Caputo, R, 1984) |
| "A 79-year-old man with severe generalized pruritus and erythema annulare centrifugum as manifestations of his idiopathic hypereosinophilic syndrome slowly responded to long-term therapy with ketoconazole and dapsone." | 3.67 | Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy. ( Shelley, ED; Shelley, WB, 1985) |
| "A Burmese boy being treated with dapsone (diaminodiphenylsulfone [DDS]), 100 mg daily, for lepromatous leprosy had a fatal reaction to the drug 3 weeks after therapy was started." | 3.66 | Fatal reaction to dapsone during treatment of leprosy. ( Borkowsky, W; Bullock, WE; Frey, HM; Gershon, AA, 1981) |
| "A patient with a 20-year history is presented as a classic example of erythema elevatum diutinum, with a dramatic response to dapsone therapy, and with interesting features of improvement during pregnancies and occurrence of giant cell tumors of soft tissue, neither of these latter features having been previously reported." | 3.65 | Erythema elevatum diutinum. Response to dapsone. ( Fort, SL; Rodman, OG, 1977) |
| " Safety profile assessments included adverse events (AEs), physical examinations, laboratory tests, and local tolerability assessments." | 2.82 | Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. ( Berk, DR; Chang-Lin, JE; Jarratt, MT; Jones, TM; Kaoukhov, A; Lin, V; Tong, W, 2016) |
| "Panniculitis is a recognized, but rare complication of α1-antitrypsin (A1AT) deficiency." | 2.50 | Alpha-1-antitrypsin deficiency-associated panniculitis: a case report. ( Cardoso, J; Carvalho, R; Chaveiro, A; Laureano, A, 2014) |
| "Dapsone alone was inefficient." | 1.48 | Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus? ( Abida, O; Bahloul, E; Bouzid, A; Charfi, S; Feki, S; Hachicha, H; Jerbi, A; Masmoudi, A; Masmoudi, H; Sellami Boudawara, T; Sellami, K; Turki, H, 2018) |
| "A 19-year-old Japanese man had been treated for ulcerative colitis for 2 years." | 1.37 | A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory ( Danno, K; Fujimoto, N; Tanaka, T; Uenishi, T; Wakabayashi, M, 2011) |
| "Dapsone was used in the treatment of this patient, and partial regression of the lesions was achieved within 15 days, even before anti-retroviral therapy was prescribed." | 1.33 | Erythema elevatum diutinum as a first clinical manifestation for diagnosing HIV infection: case history. ( Arruda, LH; Bittencourt, C; Cintra, ML; Discacciati, MP; Rover, PA; Zaniboni, MC, 2005) |
| "Treatment with dapsone was effective for his skin and nails until he developed generalized lymphadenopathy which turned out to be malignant lymphoma." | 1.31 | A case of erythema elevatum diutinum associated with B-cell lymphoma: a rare distribution involving palms, soles and nails. ( Futei, Y; Konohana, I, 2000) |
| "A 35-year-old woman suffering from Crohn's disease for 3 years developed painful erythematous nodular lesions predominantly on the dorsa of her hands and feet, as well as on her elbows and wrists." | 1.29 | [Erythema elevatum and diutinum in Crohn disease]. ( Elsner, J; Kapp, A; Kiehl, P; Weiss, J, 1996) |
| "Dapsone has been shown to possess anti-inflammatory activity in a variety of animal models." | 1.26 | The anti-inflammatory profile of dapsone in animal models of inflammation. ( Gemmell, DK; Lewis, AJ; Stimson, WH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (32.79) | 18.7374 |
| 1990's | 14 (22.95) | 18.2507 |
| 2000's | 9 (14.75) | 29.6817 |
| 2010's | 14 (22.95) | 24.3611 |
| 2020's | 4 (6.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chastagner, M | 1 |
| Shourik, J | 1 |
| Jachiet, M | 1 |
| Battistella, M | 1 |
| Lefevre, G | 1 |
| Gibier, JB | 1 |
| Aubert, H | 1 |
| Musquer, M | 1 |
| Descamps, V | 1 |
| Deschamps, L | 1 |
| Chosidow, O | 1 |
| Ortonne, N | 2 |
| Groh, M | 1 |
| Bernier, M | 1 |
| Jullien, D | 1 |
| Chasset, F | 1 |
| Staumont-Salle, D | 1 |
| Bouaziz, JD | 1 |
| Kanitakis, J | 1 |
| Villani, AP | 1 |
| Tabata, MM | 1 |
| Lin, WM | 1 |
| Goldstein, J | 1 |
| Quinn, TR | 1 |
| Chen, ST | 1 |
| Vargas-Mora, P | 1 |
| Arceu, M | 1 |
| Cortés, A | 1 |
| Carreño, L | 1 |
| Kaur, M | 1 |
| Ramam, M | 1 |
| Patra, S | 1 |
| Khurana, U | 1 |
| Asati, DP | 1 |
| Van-de-Velde, V | 2 |
| Matthews, AG | 2 |
| Biswas, A | 2 |
| Jerbi, A | 1 |
| Hachicha, H | 1 |
| Feki, S | 1 |
| Bahloul, E | 1 |
| Sellami, K | 1 |
| Abida, O | 1 |
| Charfi, S | 1 |
| Bouzid, A | 1 |
| Sellami Boudawara, T | 1 |
| Turki, H | 1 |
| Masmoudi, A | 1 |
| Masmoudi, H | 1 |
| Müller, A | 1 |
| Wolfsperger, F | 1 |
| Kofler, L | 1 |
| Yazdi, AS | 1 |
| Da Silva Sousa, AC | 1 |
| Campos, M | 1 |
| Oliveira, A | 1 |
| Menezes, N | 1 |
| Tente, D | 1 |
| Baptista, A | 1 |
| Dolenc-Voljč, M | 1 |
| Žgavec, B | 1 |
| Vizjak, A | 1 |
| Tenyi, V | 1 |
| Luzar, B | 1 |
| Laureano, A | 1 |
| Carvalho, R | 1 |
| Chaveiro, A | 1 |
| Cardoso, J | 1 |
| Manriquez, J | 1 |
| Berroeta-Mauriziano, D | 1 |
| Andino-Navarrete, R | 1 |
| Vera-Kellet, C | 1 |
| Alharbi, R | 1 |
| Peric, J | 1 |
| Wolff, H | 2 |
| Wollenberg, A | 1 |
| Jarratt, MT | 1 |
| Jones, TM | 1 |
| Chang-Lin, JE | 1 |
| Tong, W | 1 |
| Berk, DR | 1 |
| Lin, V | 1 |
| Kaoukhov, A | 1 |
| Barzegar, M | 1 |
| Davatchi, CC | 1 |
| Akhyani, M | 1 |
| Nikoo, A | 1 |
| Daneshpazhooh, M | 1 |
| Farsinejad, K | 1 |
| Becker, L | 1 |
| Kowalewski, C | 1 |
| Martin, JM | 1 |
| do Valle, SO | 1 |
| França, AT | 1 |
| Pires, GV | 1 |
| Guimarães, P | 1 |
| Dias, GA | 1 |
| Levy, SA | 1 |
| Maksimovic, L | 1 |
| Duriez, P | 1 |
| Lascaux-Cametz, AS | 1 |
| Andre, C | 1 |
| Bagot, M | 1 |
| Revuz, J | 1 |
| Wakabayashi, M | 1 |
| Fujimoto, N | 1 |
| Uenishi, T | 1 |
| Danno, K | 1 |
| Tanaka, T | 1 |
| Hirahara, K | 1 |
| Kano, Y | 1 |
| Asano, Y | 1 |
| Shiohara, T | 1 |
| Aldave, AJ | 1 |
| Shih, JL | 1 |
| Jovkar, S | 1 |
| McLeod, SD | 1 |
| Mitamura, Y | 1 |
| Fujiwara, O | 1 |
| Miyanishi, K | 1 |
| Sato, H | 1 |
| Saga, K | 1 |
| Ohtsuka, K | 1 |
| Bahadir, S | 1 |
| Cobanoglu, U | 1 |
| Cimsit, G | 1 |
| Yayli, S | 1 |
| Alpay, K | 1 |
| Rover, PA | 1 |
| Bittencourt, C | 1 |
| Discacciati, MP | 1 |
| Zaniboni, MC | 1 |
| Arruda, LH | 1 |
| Cintra, ML | 1 |
| Demitsu, T | 1 |
| Kakurai, M | 1 |
| Azuma, R | 1 |
| Hiratsuka, Y | 1 |
| Umemoto, N | 1 |
| Yoneda, K | 1 |
| Ramsey, ML | 1 |
| Gibson, B | 1 |
| Tschen, JA | 1 |
| Wolf, JE | 1 |
| Caputo, R | 1 |
| Alessi, E | 1 |
| Frey, HM | 1 |
| Gershon, AA | 1 |
| Borkowsky, W | 1 |
| Bullock, WE | 1 |
| Ossowski, B | 1 |
| Baum, C | 1 |
| Wayte, JA | 1 |
| Rogers, S | 1 |
| Powell, FC | 1 |
| Lyde, CB | 1 |
| Cox, SE | 1 |
| Cruz, PD | 1 |
| Farella, V | 1 |
| Lotti, T | 1 |
| Difonzo, EM | 1 |
| Panconesi, EX | 1 |
| Cole, HP | 1 |
| Wesley, RE | 1 |
| King, LE | 1 |
| Bachmeyer, C | 1 |
| Aractingi, S | 1 |
| Panzarella, K | 1 |
| Camisa, C | 1 |
| Elsner, J | 1 |
| Kiehl, P | 1 |
| Kapp, A | 1 |
| Weiss, J | 1 |
| Ganapati, R | 1 |
| Pai, VV | 1 |
| Banerji, U | 1 |
| Thomas, J | 1 |
| Saha, B | 1 |
| Suárez, J | 1 |
| Miguélez, M | 1 |
| Villalba, R | 1 |
| Kontochristopoulos, G | 1 |
| Stavropoulos, P | 1 |
| Panteleos, D | 1 |
| Aroni, K | 1 |
| Kunte, C | 1 |
| Loeser, C | 1 |
| Nakajima, H | 1 |
| Ikeda, M | 1 |
| Yamamoto, Y | 1 |
| Kodama, H | 1 |
| Futei, Y | 1 |
| Konohana, I | 1 |
| Fakheri, A | 1 |
| Gupta, SM | 1 |
| White, SM | 1 |
| Don, PC | 1 |
| Weinberg, JM | 1 |
| Katz, SI | 2 |
| Gallin, JI | 1 |
| Hertz, KC | 1 |
| Fauci, AS | 1 |
| Lawley, TJ | 1 |
| Lewis, AJ | 1 |
| Gemmell, DK | 1 |
| Stimson, WH | 1 |
| Carli-Basset, C | 1 |
| Lorette, G | 1 |
| Douvion, MJ | 1 |
| Boura, R | 1 |
| Fetissof, F | 1 |
| Mizumoto, T | 1 |
| Ohkawara, A | 1 |
| Ohnishi, O | 1 |
| Aoyagi, T | 1 |
| Miura, Y | 1 |
| Tanzer, FR | 1 |
| Lynfield, YL | 1 |
| Helander, I | 1 |
| Partanen, J | 1 |
| Fort, SL | 1 |
| Rodman, OG | 1 |
| Sheskin, J | 1 |
| Walker, KD | 1 |
| Badame, AJ | 1 |
| Wozel, G | 1 |
| Barth, J | 1 |
| Shelley, WB | 1 |
| Shelley, ED | 1 |
| English, JS | 1 |
| Smith, NP | 1 |
| Kersy, PJ | 1 |
| Levene, GM | 2 |
| Jopling, WH | 1 |
| Mehta, HD | 1 |
| Thompson, DM | 1 |
| Main, RA | 1 |
| Beck, JS | 1 |
| Albert-Recht, F | 1 |
| Fraser, NG | 1 |
| Kerr, NW | 1 |
| Donald, D | 1 |
| Cream, JJ | 1 |
| Calnan, CD | 1 |
| Vollum, DI | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT01773122] | Phase 1 | 77 participants (Actual) | Interventional | 2013-01-21 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended. (NCT01773122)
Timeframe: Day 28
| Intervention | Nanograms/Milliliter (ng/mL) (Mean) |
|---|---|
| Dapsone Formulation A | 11.7 |
| Dapsone Formulation B | 14.1 |
| Dapsone Formulation C | 13.0 |
| Dapsone 5% Gel | 17.6 |
Cmax is the maximum plasma level following multiple doses of dapsone. Plasma is the liquid component of the blood in which the blood cells are suspended. The dapsone metabolites are N-acetyl dapsone and dapsone hydroxylamine. (NCT01773122)
Timeframe: Day 28
| Intervention | Nanograms/Milliliter (ng/mL) (Mean) | |
|---|---|---|
| N-Acetyl Dapsone | Dapsone Hydroxylamine | |
| Dapsone 5% Gel | 11.7 | 1.47 |
| Dapsone Formulation A | 5.44 | 0.908 |
| Dapsone Formulation B | 6.00 | 1.11 |
| Dapsone Formulation C | 6.47 | 1.19 |
4 reviews available for dapsone and Erythema
| Article | Year |
|---|---|
Treatment of Eosinophilic Annular Erythema: Retrospective multicenter study and literature review.
Topics: Adrenal Cortex Hormones; Dapsone; Eosinophilia; Erythema; Humans; Hydroxychloroquine; Multicenter St | 2022 |
Alpha-1-antitrypsin deficiency-associated panniculitis: a case report.
Topics: alpha 1-Antitrypsin Deficiency; Biopsy; Colchicine; Contraindications; Dapsone; Erythema; Female; Gl | 2014 |
Pemphigus erythematosus in a five-year-old child.
Topics: Administration, Oral; Child; Dapsone; Erythema; Female; Humans; Pemphigus; Prednisone | 1994 |
Dermatitis herpetiformis. Clinical, histologic, therapeutic and laboratory clues.
Topics: Dapsone; Dermatitis Herpetiformis; Erythema; Humans; Immunoglobulin A; Male; Middle Aged; Skin; Sulf | 1978 |
2 trials available for dapsone and Erythema
| Article | Year |
|---|---|
Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Infective Agents; Dapsone; Double-Bl | 2016 |
A multicenter study of recombinant interferon-alpha 2b in the treatment of multibacillary leprosy.
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Erythema; Humans; Interferon Type I; Lepromin; Lepr | 1997 |
55 other studies available for dapsone and Erythema
| Article | Year |
|---|---|
Localised chronic fibrosing vasculitis versus erythema elevatum diutinum.
Topics: Dapsone; Erythema; Female; Fibrosis; Granuloma; Humans; Plasma Cells; Vasculitis; Vasculitis, Leukoc | 2023 |
Multiple annular plaques in an adult woman.
Topics: Cetirizine; Dapsone; Eosinophilia; Erythema; Female; Humans; Hydroxychloroquine; Middle Aged; Predni | 2020 |
Large erythematous annular plaques on the trunk with painful palmoplantar nodules.
Topics: Aged; Dapsone; Erythema; Humans; Leprostatic Agents; Male; Skin Abnormalities; Skin Diseases, Geneti | 2020 |
An Unusual Vesiculopustular Eruption: Challenge.
Topics: Aged; Biopsy, Needle; Dapsone; Diagnosis, Differential; Erythema; Female; Humans; Immunoglobulin A; | 2018 |
Pemphigus herpetiformis in South Tunisia: a clinical expression of pemphigus foliaceus?
Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Complement C3; Dapsone; Desmoglein 1; Erythem | 2018 |
An Unusual Vesiculopustular Eruption: Answer.
Topics: Aged; Biopsy, Needle; Dapsone; Diagnosis, Differential; Erythema; Female; Fluorescent Antibody Techn | 2018 |
Multiple livid-erythematous macules and plaques with slight scaling in a young man.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Erythema; Humans; Lep | 2018 |
Bullous lupus erythematosus with an erythema gyratum repens-like pattern.
Topics: Anti-Infective Agents; Dapsone; Erythema; Female; Foot Dermatoses; Glucocorticoids; Hand Dermatoses; | 2019 |
Figurate erythema in a patient with bullous pemphigoid and Toxocara infection.
Topics: Aged; Animals; Anti-Bacterial Agents; Biopsy, Needle; Dapsone; Erythema; Female; Fluorescent Antibod | 2013 |
Eosinophilic annular erythema: complete clinical response with dapsone.
Topics: Adult; Dapsone; Eosinophilia; Erythema; Female; Humans; Remission Induction; Skin Diseases, Genetic | 2015 |
Dapsone treatment for eosinophilic anular erythema.
Topics: Anti-Infective Agents; Biopsy; Dapsone; Eosinophilia; Erythema; Female; Humans; Middle Aged; Skin; S | 2017 |
An atypical presentation of erythema elevatum diutinum involving palms and soles.
Topics: Aged; Biopsy, Needle; Dapsone; Diagnosis, Differential; Erythema; Female; Follow-Up Studies; Foot De | 2009 |
Nonpruritic erythematous plaques.
Topics: Adult; Animals; Armadillos; Biopsy; Clofazimine; Dapsone; Diagnosis, Differential; Drug Therapy, Com | 2009 |
Dapsone hypersensitivity syndrome during delayed pressure urticaria treatment.
Topics: Adult; Dapsone; Dengue; Diagnosis, Differential; Drug Hypersensitivity; Erythema; Female; Fever; His | 2010 |
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient].
Topics: Dapsone; Dermis; Erythema; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neutrophils; Py | 2010 |
A case of acne fulminans in a patient with ulcerative colitis successfully treated with prednisolone and diaminodiphenylsulfone: a literature review of acne fulminans, rosacea fulminans and neutrophilic dermatoses occurring in the setting of inflammatory
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Biopsy; Cefozopran; Cephalosporins; Colitis, Ulcerative; Da | 2011 |
Osteonecrosis of the femoral head in a patient with Henoch-Schönlein purpura and drug-induced hypersensitivity syndrome treated with corticosteroids.
Topics: Adult; Anti-Infective Agents; Dapsone; Eosinophilia; Erythema; Exanthema; Femur Head Necrosis; Fever | 2013 |
Peripheral keratitis associated with erythema elevatum diutinum.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Erythema; Humans; Keratitis; Male; Vasculit | 2003 |
Nodular scleritis and panuveitis with erythema elevatum diutinum.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Drug Therapy, Combination; Erythema; Female | 2004 |
Erythema dyschromicum perstans: response to dapsone therapy.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Back; Dapsone; Diagnosis, Differential; Erythem | 2004 |
Erythema elevatum diutinum as a first clinical manifestation for diagnosing HIV infection: case history.
Topics: Anti-Infective Agents; Dapsone; Erythema; HIV Infections; Humans; Male; Middle Aged; Vasculitis, Leu | 2005 |
Neutrophilic, urticaria-like erythema associated with immunoglobulin A monoclonal gammopathy of undetermined significance.
Topics: Aged; Anti-Infective Agents; Dapsone; Erythema; Humans; Immunoglobulin A; Male; Paraproteinemias | 2008 |
Erythema elevatum diutinum.
Topics: Adult; Dapsone; Elbow; Erythema; Hand Dermatoses; Humans; Leg Dermatoses; Male | 1984 |
Unique aspects of a lesion of erythema elevatum diutinum.
Topics: Aged; Dapsone; Erythema; Fibroblasts; Humans; Male; Neutrophils; Skin | 1984 |
Fatal reaction to dapsone during treatment of leprosy.
Topics: Adolescent; Dapsone; Erythema; Humans; Leprosy; Male; Skin; Thalidomide | 1981 |
[Pseudoglucagonoma syndrome. Case report, therapeutic possibilities and hypotheses on the etiology].
Topics: Administration, Oral; Aged; Dapsone; Diagnosis, Differential; Erythema; Female; Glucagonoma; Humans; | 1995 |
Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
Topics: Adult; Dapsone; Drug Therapy, Combination; Erythema; Humans; Immunoglobulin A; Male; Minocycline; Mo | 1995 |
Erythema elevatum diutinum.
Topics: Biopsy; Clofazimine; Dapsone; Erythema; Female; Fluorescent Antibody Technique; Hematologic Tests; H | 1994 |
Brown recluse spider envenomation of the eyelid: an animal model.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antivenins; Combined Modality Therapy; Dap | 1995 |
Erythema elevatum diutinum with HIV-2 infection.
Topics: Acquired Immunodeficiency Syndrome; Anti-Infective Agents; Dapsone; Erythema; Hand Dermatoses; HIV-2 | 1996 |
Coexistence of superficial pemphigus and psoriasis.
Topics: Anti-Inflammatory Agents; Antigenic Modulation; Autoimmune Diseases; Dapsone; Erythema; Etretinate; | 1996 |
[Erythema elevatum and diutinum in Crohn disease].
Topics: Adult; Anti-Infective Agents; Antigen-Antibody Complex; Crohn Disease; Dapsone; Erythema; Female; Fo | 1996 |
Nodular erythema elevatum diutinum in an HIV-1 infected woman: response to dapsone and antiretroviral therapy.
Topics: Adult; Antiviral Agents; Dapsone; Erythema; Female; HIV Infections; HIV-1; Humans; Vasculitis, Leuko | 1998 |
Erythema dyschromicum perstans: response to dapsone therapy.
Topics: Adult; Anti-Infective Agents; Dapsone; Erythema; Female; Humans; Male; Pigmentation Disorders; Treat | 1998 |
Folliculitis spinulosa decalvans: successful therapy with dapsone.
Topics: Adrenal Cortex Hormones; Adult; Alopecia; Anti-Inflammatory Agents, Non-Steroidal; Blepharitis; Cica | 1998 |
Erythema elevatum diutinum complicated by rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Dapsone; E | 1999 |
A case of erythema elevatum diutinum associated with B-cell lymphoma: a rare distribution involving palms, soles and nails.
Topics: Anti-Infective Agents; Dapsone; Erythema; Foot Diseases; Humans; Lymphoma, B-Cell; Male; Middle Aged | 2000 |
Erythema elevatum diutinum in a patient with human immunodeficiency virus.
Topics: Anti-Infective Agents; Dapsone; Erythema; HIV Infections; Humans; Leg Dermatoses; Male; Middle Aged | 2001 |
Erythema elevatum diutinum: skin and systemic manifestations, immunologic studies, and successful treatment with dapsone.
Topics: Adolescent; Arthus Reaction; Chemotaxis, Leukocyte; Child; Dapsone; Erythema; Female; Humans; Immuno | 1977 |
The anti-inflammatory profile of dapsone in animal models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; | 1978 |
[Pustular psoriasis of the erythema annulare centrifugum type. Treatment with disulone].
Topics: Adolescent; Adult; Dapsone; Erythema; Female; Humans; Middle Aged; Psoriasis | 1979 |
[Erythema elevatum diutinum, a variant of cutaneous vasculitis].
Topics: Dapsone; Dexamethasone; Ear, External; Erythema; Foot; Humans; Male; Middle Aged; Penis; Vasculitis, | 1977 |
Erythema elevatum diutinum.
Topics: Aged; Arthritis, Rheumatoid; Dapsone; Erythema; Humans; Leg Ulcer; Male; Prednisone; Skin Diseases; | 1978 |
Dapsone-induced distal axonal degeneration of the motor neurons.
Topics: Adult; Axons; Dapsone; Erythema; Female; Humans; Motor Neurons; Nerve Degeneration; Polyneuropathies | 1978 |
Erythema elevatum diutinum. Response to dapsone.
Topics: Adult; Dapsone; Erythema; Female; Giant Cell Tumors; Humans; Pregnancy; Soft Tissue Neoplasms | 1977 |
The case for invisible leprosy.
Topics: Child; Dapsone; Diagnosis, Differential; Erythema; Female; Humans; Israel; Leprosy; Periodicity; Rem | 1975 |
Erythema elevatum diutinum in a patient with Crohn's disease.
Topics: Adult; Antigen-Antibody Complex; Biopsy; Crohn Disease; Dapsone; Erythema; Female; Humans; Immunoglo | 1990 |
[The REM syndrome--alternative therapeutic possibilities].
Topics: Adult; Chloroquine; Dapsone; Erythema; Female; Humans; Mucins; PUVA Therapy | 1987 |
Erythema annulare centrifugum as the presenting sign of the hypereosinophilic syndrome: observations on therapy.
Topics: Aged; Dapsone; Drug Therapy, Combination; Eosinophilia; Erythema; Humans; Ketoconazole; Male; Syndro | 1985 |
Erythema elevatum diutinum--an unusual case.
Topics: Dapsone; Erythema; Female; Humans; Middle Aged; Skin | 1985 |
A case of leprous nodular interstitial myositis.
Topics: Adrenocorticotropic Hormone; Adult; Dapsone; Edema; Erythema; Humans; Ichthyosis; Leprosy; Male; Myo | 1972 |
Studies on a patient with leucocytoclastic vasculities 'pyoderma gangrenosum' and paraproteinaemia.
Topics: Antigens, Bacterial; Biopsy; Blood Protein Disorders; Blood Protein Electrophoresis; Dapsone; Erythe | 1973 |
Oral lesions in dermatitis herpetiformis.
Topics: Adolescent; Adult; Aged; Biopsy; Blister; Dapsone; Denture, Complete; Dermatitis Herpetiformis; Eryt | 1973 |
Erythema elevatum diutinum: an unusual reaction to streptococcal antigen and response to dapsone.
Topics: Antigens; Antigens, Bacterial; Biopsy; Dapsone; Erythema; Female; Hemorrhage; Humans; Leukocytes; Ma | 1971 |
Erythema elevatum diutinum--vesicular lesions and sulphone response.
Topics: Adult; Child; Child, Preschool; Dapsone; Erythema; Female; Humans; Male; Seasons | 1968 |